Aldeyra Therapeutics Forecast and Stock Analysis
Technical ALDX stock analysis for March 19, 2019.
Aldeyra Therapeutics gained 0.85% in the last trading day, rising from $8.26 to $8.33 The price has been going up and down for this period, and there has been a 3.48% gain for the last 2 weeks. Volume fell in the last day by -34 981 shares, and in total, 161 960 shares bought and sold for approximately $1.35 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Tuesday, 19th Mar 2019) of the ALDX stock was $8.33. This is 0.85% more than the trading day before Monday, 18th Mar 2019.
During day the stock fluctuated 4.31% from a day low at $8.25 to a day high of $8.60.
30 day high of the ALDX stock price was $9.51 and low was $7.05.
90 day high was $10.05 and low was $7.05.
52 week high for the Aldeyra Therapeutics - $16.70 and low - $6.75.
Aldeyra Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.28% during the next 3 months and, with 90% probability hold a price between $6.23 and $8.77 at the end of this period.
Aldeyra Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $8.57. On a fall, the stock will find some support from the long-term average at approximately $8.22. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday March 18, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 53 and the stock is currently not being overbought or oversold
Support & Resistance
Aldeyra Therapeutics finds support from accumulated volume at $8.00.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.36 between high and low, or 4.31%. For the last week the stock has had a daily average volatility of 6.67%.
Our recommended stoploss: $7.84 (-5.84%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Aldeyra Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.